Literature DB >> 3427457

Alterations in local cerebral glucose utilization induced by phencyclidine.

A D Weissman1, M Dam, E D London.   

Abstract

The effects of phencyclidine (PCP; 0.5, 1,5, 10 mg/kg, i.v.) on local cerebral glucose utilization (LCGU) in the rat were studied with the 2-deoxy-D-[1-14C]glucose method. Significant findings were obtained in 41 of 87 brain regions of PCP-treated rats (25-270% of control). Rates of LCGU increased throughout the limbic system, except the habenula. Although LCGU increased in most sensory structures, it decreased in specific layers of the somatosensory and auditory cortices and the inferior colliculus. Evidence was seen for dissociation between LCGU responses of specific thalamic relay areas and their terminal fields in the cortex. Increases in LCGU occurred throughout the motor system, manifesting a striking pattern of columnar activity in the motor cortex. However, LCGU was reduced in the frontal cortical pole. Elevated LCGU was observed in the pontine nuclei and the nuclei and the nucleus solitarius. Effects of 5 mg/kg PCP diminished with time although 8 regions maintained a metabolic alteration at 180 min. PCP induced several behaviors, including stereotypies, which varied with the dose and time after drug administration. The results demonstrate a PCP-induced activation of various functional circuits in the brain, especially the limbic system, and may provide a physiological basis for PCP's psychotomimetic properties.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3427457     DOI: 10.1016/0006-8993(87)91583-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo.

Authors:  J McCulloch; L L Iversen
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

2.  Regional metabolite levels and turnover in the awake rat brain under the influence of nicotine.

Authors:  Jie Wang; Lihong Jiang; Yifeng Jiang; Xiaoxian Ma; Golam M I Chowdhury; Graeme F Mason
Journal:  J Neurochem       Date:  2010-03-14       Impact factor: 5.372

3.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 4.  Is rheumatoid arthritis a failure of B cell death in synovium?

Authors:  J C Edwards; J Cambridge
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

5.  Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.

Authors:  Alessandro Gozzi; Valerio Crestan; Giuliano Turrini; Marcel Clemens; Angelo Bifone
Journal:  Psychopharmacology (Berl)       Date:  2010-01-29       Impact factor: 4.530

Review 6.  The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.

Authors:  Sanna K Janhunen; Heta Svärd; John Talpos; Gaurav Kumar; Thomas Steckler; Niels Plath; Linda Lerdrup; Trine Ruby; Marie Haman; Roger Wyler; Theresa M Ballard
Journal:  Psychopharmacology (Berl)       Date:  2015-06-14       Impact factor: 4.530

7.  Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat.

Authors:  Alessandro Gozzi; Hugh Herdon; Adam Schwarz; Simone Bertani; Valerio Crestan; Giuliano Turrini; Angelo Bifone
Journal:  Psychopharmacology (Berl)       Date:  2008-08-15       Impact factor: 4.530

8.  Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.

Authors:  Alice Egerton; Lee Reid; Sandie McGregor; Susan M Cochran; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2008-04-23       Impact factor: 4.530

Review 9.  Modelling prefrontal cortex deficits in schizophrenia: implications for treatment.

Authors:  J A Pratt; C Winchester; A Egerton; S M Cochran; B J Morris
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

10.  Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease.

Authors:  Frank Leypoldt; Ralph Buchert; Ingo Kleiter; Jörg Marienhagen; Mathias Gelderblom; Tim Magnus; Josep Dalmau; Christian Gerloff; Jan Lewerenz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-05-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.